EP1c times for angiotensin: EP1 receptors facilitate angiotensin II-induced vascular dysfunction

Hypertension

Volumn 55, Issue 4, 2010, Pages 846-848

  Pena Silva, Ricardo A ^a,b   Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ANGIOTENSIN II; CYCLOOXYGENASE 1; PROSTAGLANDIN E RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; PROSTAGLANDIN E2; PROSTANOID RECEPTOR EP1;

BRAIN BLOOD VESSEL; CALCIUM CELL LEVEL; CEREBROVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME METABOLISM; HUMAN; HYPERTENSION; NONHUMAN; NOTE; OXIDATIVE STRESS; PRESSOR RESPONSE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR DISEASE; ANIMAL; BLOOD VESSEL; BRAIN CIRCULATION; METABOLISM; PATHOPHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; BLOOD VESSELS; CEREBROVASCULAR CIRCULATION; DINOPROSTONE; HUMANS; RECEPTORS, PROSTAGLANDIN E;

EID: 77950479194     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.148346     Document Type: Note

References (13)

1. Chrissobolis S, Faraci FM. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med. 2008;14: 495-502.
2. 2 and EP1 receptors are required for the cere-brovascular dysfunction induced by angiotensin II. Hypertension. 2010; 55:911-917.
3. Yang D, Feletou M, Levens N, Zhang JN, Vanhoutte PM. A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR. Hypertension. 2003;41:143-148.
4. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and-2 activity on the pressor response to angiotensin II. J Clin Invest. 2002;110:61-69.
5. Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, Segnani C, Ippolito C, Antonioli L, Blandizzi C, Taddei S, Salvetti A, Del TM. Cyclooxygenase-1 is involved in endothelial dysfunction of mes-enteric small arteries from angiotensin II-infused mice. Hypertension. 2007;49:679-686.
6. Francois H, Athirakul K, Mao L, Rockman H, Coffman TM. Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension. 2004;43:364-369.
7. Guan Y, Zhang Y, Wu J, Qi Z, Yang G, Dou D, Gao Y, Chen L, Zhang X, Davis LS, Wei M, Fan X, Carmosino M, Hao C, Imig JD, Breyer RM, Breyer MD. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J Clin Invest. 2007;117: 2496-2505.
8. Purdy KE, Arendshorst WJ. Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC. Am J Physiol. 1999;277:F850-F858.
9. Barnes PJ. Receptor heterodimerization: a new level of cross-talk. J Clin Invest. 2006;116:1210-1212.
10. Jia Z, Guo X, Zhang H, Wang MH, Dong Z, Yang T. Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against an-giotensin II-induced hypertension via inhibition of oxidative stress. Hypertension. 2008;52:952-959.
11. Fang X, Faraci FM, Kaduce TL, Harmon S, Modrick ML, Hu S, Moore SA, Falck JR, Weintraub NL, Spector AA. 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase. Am J Physiol Heart Circ Physiol. 2006;291:H2301-H2307.
12. Jadhav V, Jabre A, Chen MF, Lee TJ. Presynaptic prostaglandin E2 EP1-receptor facilitation of cerebral nitrergic neurogenic vasodilation. Stroke. 2009;40:261-269.
13. Cheng ZJ, Finckenberg P, Louhelainen M, Merasto S, Tikkanen I, Vapaatalo H, Mervaala EM. Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27). Eur J Pharmacol. 2003;461:159-169.